Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 14, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 14, 2014Terminated
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:June 25, 2012Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:October 26, 2021Unknown status
Condition(s):Immune Thrombocytopenic Purpura (ITP)Last Updated:July 3, 2023Terminated
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:December 7, 2010Unknown status
Condition(s):Primary Immune ThrombocytopeniaLast Updated:April 12, 2023Recruiting
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 12, 2019Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:August 24, 2012Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:January 18, 2018Completed
Condition(s):Primary Immune ThrombocytopeniaLast Updated:July 2, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.